Literature DB >> 33350010

A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS-CoV-2.

Lilian Peñalver1, Philipp Schmid1,2, Dávid Szamosvári1, Stefan Schildknecht3,4, Christoph Globisch5, Kevin Sawade5, Christine Peter5, Thomas Böttcher1,2.   

Abstract

Activity-based probes are valuable tools for chemical biology. However, finding probes that specifically target the active site of an enzyme remains a challenging task. Herein, we present a ligand selection strategy that allows to rapidly tailor electrophilic probes to a target of choice and showcase its application for the two cysteine proteases of SARS-CoV-2 as proof of concept. The resulting probes were specific for the active site labeling of 3CLpro and PLpro with sufficient selectivity in a live cell model as well as in the background of a native human proteome. Exploiting the probes as tools for competitive profiling of a natural product library identified salvianolic acid derivatives as promising 3CLpro inhibitors. We anticipate that our ligand selection strategy will be useful to rapidly develop customized probes and discover inhibitors for a wide range of target proteins also beyond corona virus proteases.
© 2020 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Entities:  

Keywords:  ABPP; chemical probes; enzyme inhibitors; labeling; proteases

Mesh:

Substances:

Year:  2021        PMID: 33350010      PMCID: PMC7986205          DOI: 10.1002/anie.202016113

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  39 in total

1.  Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2*.

Authors:  Merel A T van de Plassche; Marta Barniol-Xicota; Steven H L Verhelst
Journal:  Chembiochem       Date:  2020-09-09       Impact factor: 3.164

Review 2.  Activity-based protein profiling for the functional annotation of enzymes.

Authors:  Katherine T Barglow; Benjamin F Cravatt
Journal:  Nat Methods       Date:  2007-10       Impact factor: 28.547

Review 3.  Different network pharmacology mechanisms of Danshen-based Fangjis in the treatment of stable angina.

Authors:  Guo-Xia Zhang; Ying-Ying Zhang; Xiao-Xu Zhang; Peng-Qian Wang; Jun Liu; Qiong Liu; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2018-02-08       Impact factor: 6.150

4.  Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds.

Authors:  Anh-Tien Ton; Francesco Gentile; Michael Hsing; Fuqiang Ban; Artem Cherkasov
Journal:  Mol Inform       Date:  2020-03-23       Impact factor: 4.050

5.  Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction.

Authors:  Xiaoyu Xue; Haitao Yang; Wei Shen; Qi Zhao; Jun Li; Kailin Yang; Cheng Chen; Yinghua Jin; Mark Bartlam; Zihe Rao
Journal:  J Mol Biol       Date:  2006-12-01       Impact factor: 5.469

6.  Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.

Authors:  Jasper Fuk-Woo Chan; Kin-Hang Kok; Zheng Zhu; Hin Chu; Kelvin Kai-Wang To; Shuofeng Yuan; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2020-01-28       Impact factor: 7.163

7.  A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS-CoV-2.

Authors:  Lilian Peñalver; Philipp Schmid; Dávid Szamosvári; Stefan Schildknecht; Christoph Globisch; Kevin Sawade; Christine Peter; Thomas Böttcher
Journal:  Angew Chem Int Ed Engl       Date:  2021-01-28       Impact factor: 15.336

Review 8.  The SARS-CoV-2 main protease as drug target.

Authors:  Sven Ullrich; Christoph Nitsche
Journal:  Bioorg Med Chem Lett       Date:  2020-07-02       Impact factor: 2.823

9.  A novel COVID-19 and its effects on cardiovascular disease.

Authors:  Arumugam Paramasivam; Jayaseelan Vijayashree Priyadharsini; Subramanian Raghunandhakumar; Perumal Elumalai
Journal:  Hypertens Res       Date:  2020-04-30       Impact factor: 3.872

10.  Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease.

Authors:  Chunlong Ma; Michael Dominic Sacco; Brett Hurst; Julia Alma Townsend; Yanmei Hu; Tommy Szeto; Xiujun Zhang; Bart Tarbet; Michael Thomas Marty; Yu Chen; Jun Wang
Journal:  Cell Res       Date:  2020-06-15       Impact factor: 46.297

View more
  5 in total

Review 1.  Modular Approaches to Synthesize Activity- and Affinity-Based Chemical Probes.

Authors:  Antonie J van der Zouwen; Martin D Witte
Journal:  Front Chem       Date:  2021-04-15       Impact factor: 5.221

2.  A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS-CoV-2.

Authors:  Lilian Peñalver; Philipp Schmid; Dávid Szamosvári; Stefan Schildknecht; Christoph Globisch; Kevin Sawade; Christine Peter; Thomas Böttcher
Journal:  Angew Chem Int Ed Engl       Date:  2021-01-28       Impact factor: 15.336

3.  Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease in vitro.

Authors:  Yoji Kato; Akari Higashiyama; Emi Takaoka; Miyu Nishikawa; Shinichi Ikushiro
Journal:  Adv Redox Res       Date:  2021-10-08

4.  A Dual-Color Fluorescent Probe Allows Simultaneous Imaging of Main and Papain-like Proteases of SARS-CoV-2-Infected Cells for Accurate Detection and Rapid Inhibitor Screening.

Authors:  Yong Cheng; Raina M Borum; Alex E Clark; Zhicheng Jin; Colman Moore; Pavla Fajtová; Anthony J O'Donoghue; Aaron F Carlin; Jesse V Jokerst
Journal:  Angew Chem Int Ed Engl       Date:  2022-01-14       Impact factor: 16.823

5.  A Rapid SARS-CoV-2 Nucleocapsid Protein Profiling Assay with High Sensitivity Comparable to Nucleic Acid Detection.

Authors:  Jie Liu; Jinpeng Mao; Mengyu Hou; Zhian Hu; Gongwei Sun; Sichun Zhang
Journal:  Anal Chem       Date:  2022-10-12       Impact factor: 8.008

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.